Literature DB >> 12960041

Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene.

András K Fülöp1, Anna Földes, Edit Buzás, Krisztina Hegyi, Ildikó H Miklós, László Romics, Monika Kleiber, András Nagy, András Falus, Krisztina J Kovács.   

Abstract

Histamine has been referred to as an anorexic factor that decreases appetite and fat accumulation and affects feeding behavior. Tuberomammillary histaminergic neurons have been implicated in central mediation of peripheral metabolic signals such as leptin, and centrally released histamine inhibits ob gene expression. Here we have characterized the metabolic phenotype of mice that completely lack the ability to produce histamine because of targeted disruption of the key enzyme in histamine biosynthesis (histidine decarboxylase, HDC). Histochemical analyses confirmed the lack of HDC mRNA, histamine immunoreactivity, and histaminergic innervation throughout the brain of gene knockout mouse. Aged histamine-deficient (HDC-/-) mice are characterized by visceral adiposity, increased amount of brown adipose tissue, impaired glucose tolerance, hyperinsulinemia, and hyperleptinemia. Histamine-deficient animals are not hyperphagic but gain more weight and are calorically more efficient than wild-type controls. These metabolic changes presumably are due to the impaired regulatory loop between leptin and hypothalamic histamine that results in orexigenic dominance through decreased energy expenditure, attenuated ability to induce uncoupling protein-1 mRNA in the brown adipose tissue and defect in mobilizing energy stores. Our results further support the role of histamine in regulation of energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960041     DOI: 10.1210/en.2003-0222

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

1.  H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Authors:  Vineesh V Raveendran; Karen M Kassel; Donald D Smith; James P Luyendyk; Kurt J Williams; Rachel Cherian; Gregory A Reed; Colleen A Flynn; Iván L Csanaky; Andrew L Lickteig; Matthew J Pratt-Hyatt; Curtis D Klaassen; Kottarappat N Dileepan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

Review 2.  Amine oxidase substrates for impaired glucose tolerance correction.

Authors:  C Carpéné; S Bour; V Visentin; F Pellati; S Benvenuti; M C Iglesias-Osma; M J García-Barrado; P Valet
Journal:  J Physiol Biochem       Date:  2005-06       Impact factor: 4.158

Review 3.  Histamine receptor signaling in energy homeostasis.

Authors:  Iustin V Tabarean
Journal:  Neuropharmacology       Date:  2015-06-21       Impact factor: 5.250

4.  Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.

Authors:  Gustavo Provensi; Roberto Coccurello; Hayato Umehara; Leonardo Munari; Giacomo Giacovazzo; Nicoletta Galeotti; Daniele Nosi; Silvana Gaetani; Adele Romano; Anna Moles; Patrizio Blandina; Maria Beatrice Passani
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

5.  VMAT2 identified as a regulator of late-stage β-cell differentiation.

Authors:  Daisuke Sakano; Nobuaki Shiraki; Kazuhide Kikawa; Taiji Yamazoe; Masateru Kataoka; Kahoko Umeda; Kimi Araki; Di Mao; Shirou Matsumoto; Naomi Nakagata; Olov Andersson; Didier Stainier; Fumio Endo; Kazuhiko Kume; Motonari Uesugi; Shoen Kume
Journal:  Nat Chem Biol       Date:  2013-12-15       Impact factor: 15.040

6.  Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice.

Authors:  Ke-Yong Wang; Akihide Tanimoto; Sohsuke Yamada; Xin Guo; Yan Ding; Teruo Watanabe; Takeshi Watanabe; Kimitoshi Kohno; Ken-Ichi Hirano; Hideo Tsukada; Yasuyuki Sasaguri
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

7.  Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.

Authors:  Ryo Yoshimoto; Yasuhisa Miyamoto; Ken Shimamura; Akane Ishihara; Kazuhiko Takahashi; Hidehito Kotani; Airu S Chen; Howard Y Chen; Douglas J Macneil; Akio Kanatani; Shigeru Tokita
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

8.  Histamine oxidation in mouse adipose tissue is controlled by the AOC3 gene-encoded amine oxidase.

Authors:  Z Iffiú-Soltész; E Wanecq; D Prévot; S Grès; C Carpéné
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

9.  An immune response network associated with blood lipid levels.

Authors:  Michael Inouye; Kaisa Silander; Eija Hamalainen; Veikko Salomaa; Kennet Harald; Pekka Jousilahti; Satu Männistö; Johan G Eriksson; Janna Saarela; Samuli Ripatti; Markus Perola; Gert-Jan B van Ommen; Marja-Riitta Taskinen; Aarno Palotie; Emmanouil T Dermitzakis; Leena Peltonen
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

10.  Electrophysiological characteristics of heart ventricular papillary muscles in diabetic histidine decarboxylase knockout and wild-type mice.

Authors:  Andrea Szebeni; András Falus; Valéria Kecskeméti
Journal:  J Interv Card Electrophysiol       Date:  2009-12       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.